Literature DB >> 26869333

Sfrp5 mediates glucose-induced proliferation in rat pancreatic β-cells.

Binbin Guan1, Wenyi Li2, Fengying Li2, Yun Xie2, Qicheng Ni2, Yanyun Gu2, Xiaoying Li2, Qidi Wang2, Hongli Zhang3, Guang Ning2.   

Abstract

The cellular and molecular mechanisms of glucose-stimulated β-cell proliferation are poorly understood. Recently, secreted frizzled-related protein 5 (encoded by Sfrp5; a Wnt signaling inhibitor) has been demonstrated to be involved in β-cell proliferation in obesity. A previous study demonstrated that glucose enhanced Wnt signaling to promote cell proliferation. We hypothesized that inhibition of SFRP5 contributes to glucose-stimulated β-cell proliferation. In this study, we found that the Sfrp5 level was significantly reduced in high glucose-treated INS-1 cells, primary rat β-cells, and islets isolated from glucose-infused rats. Overexpression of SFRP5 diminished glucose-stimulated proliferation in both INS-1 cells and primary β-cells, with a concomitant inhibition of the Wnt signaling pathway and decreased cyclin D2 expression. In addition, we showed that glucose-induced Sfrp5 suppression was modulated by the PI3K/AKT pathway. Therefore, we conclude that glucose inhibits Sfrp5 expression via the PI3K/AKT pathway and hence promotes rat pancreatic β-cell proliferation.
© 2016 Society for Endocrinology.

Entities:  

Keywords:  Sfrp5; glucose; proliferation; β-cell

Mesh:

Substances:

Year:  2016        PMID: 26869333     DOI: 10.1530/JOE-15-0535

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  7 in total

Review 1.  (Re)generating Human Beta Cells: Status, Pitfalls, and Perspectives.

Authors:  Luc Baeyens; Marie Lemper; Willem Staels; Sofie De Groef; Nico De Leu; Yves Heremans; Michael S German; Harry Heimberg
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

2.  Secreted frizzled-related protein 5 promotes angiogenesis of human umbilical vein endothelial cells and alleviates myocardial injury in diabetic mice with myocardial infarction by inhibiting Wnt5a/JNK signaling.

Authors:  Nian Ding; Chenghong Zheng
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 3.  The Wnt antagonist and secreted frizzled-related protein 5: implications on lipid metabolism, inflammation, and type 2 diabetes mellitus.

Authors:  Ling-Bin Liu; Xiao-Dong Chen; Xiang-Yu Zhou; Qing Zhu
Journal:  Biosci Rep       Date:  2018-07-02       Impact factor: 3.840

4.  Sfrp5 increases glucose-stimulated insulin secretion in the rat pancreatic beta cell line INS-1E.

Authors:  Maren Carstensen-Kirberg; Karin Röhrig; Corinna Niersmann; D Margriet Ouwens; Bengt F Belgardt; Michael Roden; Christian Herder
Journal:  PLoS One       Date:  2019-03-28       Impact factor: 3.240

Review 5.  Sfrp5/Wnt Pathway: A Protective Regulatory System in Atherosclerotic Cardiovascular Disease.

Authors:  Shan Tong; Qingwei Ji; Yu Du; Xiaogang Zhu; Caizhong Zhu; Yujie Zhou
Journal:  J Interferon Cytokine Res       Date:  2019-06-13       Impact factor: 2.607

Review 6.  Secreted Frizzled Related Proteins in Cardiovascular and Metabolic Diseases.

Authors:  Hua Guan; Jin Zhang; Jing Luan; Hao Xu; Zhenghao Huang; Qi Yu; Xingchun Gou; Lixian Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-20       Impact factor: 5.555

Review 7.  Novel Biomolecules in the Pathogenesis of Gestational Diabetes Mellitus 2.0.

Authors:  Monika Ruszała; Aleksandra Pilszyk; Magdalena Niebrzydowska; Żaneta Kimber-Trojnar; Marcin Trojnar; Bożena Leszczyńska-Gorzelak
Journal:  Int J Mol Sci       Date:  2022-04-14       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.